313 related articles for article (PubMed ID: 27225479)
1. Functional Importance of a Proteoglycan Coreceptor in Pathologic Lymphangiogenesis.
Johns SC; Yin X; Jeltsch M; Bishop JR; Schuksz M; El Ghazal R; Wilcox-Adelman SA; Alitalo K; Fuster MM
Circ Res; 2016 Jul; 119(2):210-21. PubMed ID: 27225479
[TBL] [Abstract][Full Text] [Related]
2. Lymphatic endothelial heparan sulfate deficiency results in altered growth responses to vascular endothelial growth factor-C (VEGF-C).
Yin X; Johns SC; Lawrence R; Xu D; Reddi K; Bishop JR; Varner JA; Fuster MM
J Biol Chem; 2011 Apr; 286(17):14952-62. PubMed ID: 21343305
[TBL] [Abstract][Full Text] [Related]
3. Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues.
Lohela M; Heloterä H; Haiko P; Dumont DJ; Alitalo K
Am J Pathol; 2008 Dec; 173(6):1891-901. PubMed ID: 18988807
[TBL] [Abstract][Full Text] [Related]
4. Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.
Davydova N; Harris NC; Roufail S; Paquet-Fifield S; Ishaq M; Streltsov VA; Williams SP; Karnezis T; Stacker SA; Achen MG
J Biol Chem; 2016 Dec; 291(53):27265-27278. PubMed ID: 27852824
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of lymphangiogenesis.
Takahashi M; Yoshimoto T; Kubo H
Int J Hematol; 2004 Jul; 80(1):29-34. PubMed ID: 15293565
[TBL] [Abstract][Full Text] [Related]
6. Glycan Sulfation Modulates Dendritic Cell Biology and Tumor Growth.
El Ghazal R; Yin X; Johns SC; Swanson L; Macal M; Ghosh P; Zuniga EI; Fuster MM
Neoplasia; 2016 May; 18(5):294-306. PubMed ID: 27237321
[TBL] [Abstract][Full Text] [Related]
7. VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease.
D'Alessio S; Correale C; Tacconi C; Gandelli A; Pietrogrande G; Vetrano S; Genua M; Arena V; Spinelli A; Peyrin-Biroulet L; Fiocchi C; Danese S
J Clin Invest; 2014 Sep; 124(9):3863-78. PubMed ID: 25105363
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins.
Karkkainen MJ; Haiko P; Sainio K; Partanen J; Taipale J; Petrova TV; Jeltsch M; Jackson DG; Talikka M; Rauvala H; Betsholtz C; Alitalo K
Nat Immunol; 2004 Jan; 5(1):74-80. PubMed ID: 14634646
[TBL] [Abstract][Full Text] [Related]
9. Lymphangiogenesis in regenerating tissue: is VEGF-C sufficient?
Breier G
Circ Res; 2005 Jun; 96(11):1132-4. PubMed ID: 15947252
[No Abstract] [Full Text] [Related]
10. Signaling for lymphangiogenesis via VEGFR-3 is required for the early events of metastasis.
Matsumoto M; Roufail S; Inder R; Caesar C; Karnezis T; Shayan R; Farnsworth RH; Sato T; Achen MG; Mann GB; Stacker SA
Clin Exp Metastasis; 2013 Aug; 30(6):819-32. PubMed ID: 23591595
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional profiling of VEGF-A and VEGF-C target genes in lymphatic endothelium reveals endothelial-specific molecule-1 as a novel mediator of lymphangiogenesis.
Shin JW; Huggenberger R; Detmar M
Blood; 2008 Sep; 112(6):2318-26. PubMed ID: 18614759
[TBL] [Abstract][Full Text] [Related]
12. Regulation of lymphatic capillary regeneration by interstitial flow in skin.
Goldman J; Conley KA; Raehl A; Bondy DM; Pytowski B; Swartz MA; Rutkowski JM; Jaroch DB; Ongstad EL
Am J Physiol Heart Circ Physiol; 2007 May; 292(5):H2176-83. PubMed ID: 17189348
[TBL] [Abstract][Full Text] [Related]
13. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
14. Functional analyses of the bone marrow kinase in the X chromosome in vascular endothelial growth factor-induced lymphangiogenesis.
Jones D; Xu Z; Zhang H; He Y; Kluger MS; Chen H; Min W
Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2553-61. PubMed ID: 20864667
[TBL] [Abstract][Full Text] [Related]
15. [New insights into the molecular mechanisms of lymphangiogenesis and pathophysiology].
Hirakawa S
Yakugaku Zasshi; 2012; 132(2):211-4. PubMed ID: 22293702
[TBL] [Abstract][Full Text] [Related]
16. YAP and TAZ Negatively Regulate Prox1 During Developmental and Pathologic Lymphangiogenesis.
Cho H; Kim J; Ahn JH; Hong YK; Mäkinen T; Lim DS; Koh GY
Circ Res; 2019 Jan; 124(2):225-242. PubMed ID: 30582452
[TBL] [Abstract][Full Text] [Related]
17. Distinct architecture of lymphatic vessels induced by chimeric vascular endothelial growth factor-C/vascular endothelial growth factor heparin-binding domain fusion proteins.
Tammela T; He Y; Lyytikkä J; Jeltsch M; Markkanen J; Pajusola K; Ylä-Herttuala S; Alitalo K
Circ Res; 2007 May; 100(10):1468-75. PubMed ID: 17478733
[TBL] [Abstract][Full Text] [Related]
18. Molecular controls of lymphatic VEGFR3 signaling.
Deng Y; Zhang X; Simons M
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):421-9. PubMed ID: 25524775
[TBL] [Abstract][Full Text] [Related]
19. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
20. The Schlemm's canal is a VEGF-C/VEGFR-3-responsive lymphatic-like vessel.
Aspelund A; Tammela T; Antila S; Nurmi H; Leppänen VM; Zarkada G; Stanczuk L; Francois M; Mäkinen T; Saharinen P; Immonen I; Alitalo K
J Clin Invest; 2014 Sep; 124(9):3975-86. PubMed ID: 25061878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
